← Leaderboards
Alexander Sasha Krupnick
Baltimore Va Medical Center
$9,288,760
Attributed
$12,545,188
Total exposure
12
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2008–25$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,545,188 · 10
VA$0 · 2
By mechanism
R01$6,512,856 · 3
P01$4,947,394 · 4
K08$710,337 · 1
R41$288,105 · 1
F32$86,496 · 1
I01$0 · 2
Top collaborators
- Elizabeth A Jacobsen10 shared
- Daniel Kreisel4 shared
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsPlayT-LymphocyteLungMediatingImmune ResponseBaseSignal TransductionTransplantationLaboratoriesAntigen-Presenting CellsLung TransplantationOrganProtocols DocumentationImmunologicsPathway InteractionsResponseImmune SystemOrgan TransplantationPreventAnimalsDown-RegulationMouse ModelIn Vitro
Grant awards (43)
The Role of Donor-Derived Eosinophils on Lung Allograft Ischemia Reperfusion Injury$737,635
R01 · FY2025 · AI · contact PI
Early and late inflammatory events controlling lung allograft homeostasis$609,794
P01 · FY2025 · AI · contact PI
Targeting a Defined Surgical Stress-Induced Inflammatory Pathway to Improve Peri-Operative Outcomes$559,927
R01 · FY2025 · HL · contact PI
Mechanisms of Immunosurveillance for Lung Cancer-the Role of CD8+ T Cells in Tumor Tolerance Induction$0
I01 · FY2025 · VA · contact PI
Targeting a Defined Surgical Stress-Induced Inflammatory Pathway to Improve Peri-Operative Outcomes$548,729
R01 · FY2024 · HL · contact PI
Inflammatory Cellular Mechanisms for Establishing and Maintaining Lung Allograft Tolerance$429,335
P01 · FY2024 · AI · contact PI
Mechanisms of Immunosurveillance for Lung Cancer-the Role of CD8+ T Cells in Tumor Tolerance Induction$0
I01 · FY2024 · VA · contact PI
Targeting a Defined Surgical Stress-Induced Inflammatory Pathway to Improve Peri-Operative Outcomes$573,552
R01 · FY2023 · HL · contact PI
The Role of Eosinophils in the Lung Allograft$512,800
R01 · FY2023 · AI · contact PI
Inflammatory Cellular Mechanisms for Establishing and Maintaining Lung Allograft Tolerance$449,527
P01 · FY2023 · AI · contact PI
Mechanisms of Immunosurveillance for Lung Cancer-the Role of CD8+ T Cells in Tumor Tolerance Induction$0
I01 · FY2023 · VA · contact PI
The Role of Eosinophils in the Lung Allograft$512,800
R01 · FY2022 · AI · contact PI
Inflammatory Cellular Mechanisms for Establishing and Maintaining Lung Allograft Tolerance$454,631
P01 · FY2022 · AI · contact PI
Mechanisms of Immunosurveillance for Lung Cancer-the Role of CD8+ T Cells in Tumor Tolerance Induction$0
I01 · FY2022 · VA · contact PI
The Role of Eosinophils in the Lung Allograft$512,800
R01 · FY2021 · AI · contact PI
Inflammatory Cellular Mechanisms for Establishing and Maintaining Lung Allograft Tolerance$473,889
P01 · FY2021 · AI · contact PI
Inflammatory Cellular Mechanisms for Establishing and Maintaining Lung Allograft Tolerance$498,077
P01 · FY2020 · AI · contact PI
The Role of Eosinophils in the Lung Allograft$358,261
R01 · FY2020 · AI · contact PI
The Role of Eosinophils in the Lung Allograft$168,517
R01 · FY2020 · AI · contact PI
The Role of Eosinophils in the Lung Allograft$539,375
R01 · FY2019 · AI · contact PI
The Role of Central Memory CD8+ T Cells in Induction of Lung Transplant Tolerance$443,315
P01 · FY2019 · AI · contact PI
High-dose targeted and non-toxic IL-2 cytokine therapy$0
I01 · FY2019 · VA · contact PI
The Role of Central Memory CD8+ T Cells in Induction of Lung Transplant Tolerance$416,489
P01 · FY2018 · AI · contact PI
Novel Immuno-oncology Strategy for Targeted Cytotoxic Lymphocyte Activation$288,105
R41 · FY2018 · CA · contact PI
The Role of Central Memory CD8+ T Cells in Induction of Lung Transplant Tolerance$447,770
P01 · FY2017 · AI · contact PI
Mechanisms of Immunosurveillance for Lung Cancer$0
I01 · FY2017 · VA · contact PI
The Role of Central Memory CD8+ T Cells in Induction of Lung Transplant Tolerance$358,567
P01 · FY2016 · AI · contact PI
Mechanisms of Immunosurveillance for Lung Cancer$0
I01 · FY2016 · VA · contact PI
MECHANISMS OF LUNG ALLOGRAFT ACCEPTANCE$374,300
R01 · FY2015 · HL
The Role of Central Memory CD8+ T Cells in Induction of Lung Transplant Tolerance$366,000
P01 · FY2015 · AI · contact PI
Mechanisms of Immunosurveillance for Lung Cancer$0
I01 · FY2015 · VA · contact PI
MECHANISMS OF LUNG ALLOGRAFT ACCEPTANCE$372,400
R01 · FY2014 · HL
Mechanisms of Immunosurveillance for Lung Cancer$0
I01 · FY2014 · VA · contact PI
MECHANISMS OF LUNG ALLOGRAFT ACCEPTANCE$361,760
R01 · FY2013 · HL
MECHANISMS OF LUNG ALLOGRAFT ACCEPTANCE$380,000
R01 · FY2012 · HL
The Role of Non-Hematopoietic Cells in Tumor Tolerance Induction$119,913
K08 · FY2012 · CA · contact PI
The Role of Non-Hematopoietic Cells in Tumor Tolerance Induction$120,606
K08 · FY2011 · CA · contact PI
The Role of Non-Hematopoietic Cells in Tumor Tolerance Induction$120,606
K08 · FY2010 · CA · contact PI
The Role of Non-Hematopoietic Cells in Tumor Tolerance Induction$120,606
K08 · FY2009 · CA · contact PI
The Role of Non-Hematopoietic Cells in Tumor Tolerance Induction$108,000
K08 · FY2009 · CA · contact PI
The Role of Non-Hematopoietic Cells in Tumor Tolerance Induction$120,606
K08 · FY2008 · CA · contact PI
TISSUE ENGINEERING FOR DIAPHRAGMATIC RECONSTRUCTION$45,560
F32 · FY2001 · HL
TISSUE ENGINEERING FOR DIAPHRAGMATIC RECONSTRUCTION$40,936
F32 · FY2000 · HL